PASADENA, Calif., January 06, 2026--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced its intention to offer, subject to market and other conditions, $500 million ...
Global oil prices fell sharply, dollar moves worsened producers’ purchasing power, and equity markets showed far more ...